Alamo Pharmaceuticals, Avanir Pharmaceuticals deal

AVNR acquired Alamo for $4 million in cash plus $25 million in three-year notes. The deal gives AVNR a 50-person salesforce that the company plans to use for Neurodex to treat pseudobulbar affect (PB...